HBW Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Breast Discomfort Supplement Claims Were Poor Fit With Study Findings

This article was originally published in The Rose Sheet

Executive Summary

BioPharmX can support claims its Violet Iodine breast discomfort supplement is designed for women with fibrocystic breast condition, as supported by study data, but must modify claims not specific to the conditions of the women in the study, including those with premenstrual breast discomfort.


Related Content

NAD Sees Health Claims Without Clinical Trials As Risky But Possible
Consumer Health New Products Roundup





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts